This is the third edition of the South African Health Products Regulatory Authority’s (SAHPRA’s) ReguLetter that will provide a quarterly overview of regulatory decisions relating to safety alerts, recalls and rapid alerts. This edition will provide information for the period October to December 2025....
The aim of this newsletter is to disseminate regulatory information on post-marketing surveillance and pharmacovigilance activities rendered by SAHPRA, which includes responsibilities of the SAHPRA Pharmacovigilance unit, reporting tools and pharmacovigilance systems in the country....
This is the second edition of the South African Health Products Regulatory Authority’s (SAHPRA’s) ReguLetter that will provide a quarterly overview of regulatory decisions relating to safety alerts, recalls and rapid alerts. This edition will provide information for the period July to September 2025....
Welcome to the first edition of the South African Health Products Regulatory Authority’s (SAHPRA’s) ReguLetter that will provide a quarterly overview of regulatory decisions relating to safety alerts, recalls, and rapid alerts. This edition will provide information for the period April to June 2025....
AUDA-NEPAD has published its 2023 Highlights Edition on African Medicines Regulatory Harmonization (AMRH) featuring articles on: Harmony in healthcare 2023 highlights of the Good Manufacturing Practice Technical Committee Evaluation of Medicinal Products Technical Committee virtual meeting Plans for the College for African Regulatory Science Professionals ...
As we publish our 3rd edition of the Medi-Guardian (previously VigiGuardian), let us reflect on the critical importance of pharmacovigilance as part of the product lifecycle management, our drive towards attaining maturity level three (ML3) for medicines and vaccines to effectively enable access to safe...
The aim of this newsletter is to disseminate regulatory information on post-marketing surveillance and pharmacovigilance activities rendered by SAHPRA, which includes responsibilities of the SAHPRA Pharmacovigilance unit, reporting tools and pharmacovigilance systems in the country....
The aim of this newsletter is to disseminate regulatory information on post-marketing surveillance and pharmacovigilance activities rendered by SAHPRA, which includes responsibilities of the SAHPRA Pharmacovigilance unit, reporting tools and pharmacovigilance systems in the country....
The Backlog Clearance Programme has received applications for Re-submission of Windows 1 to 9. ...
